首页> 美国卫生研究院文献>Iranian Red Crescent Medical Journal >Comparison of Oral Recombinant Erythropoietin and Subcutaneous Recombinant Erythropoietin in Prevention of Anemia of Prematurity

【2h】

Comparison of Oral Recombinant Erythropoietin and Subcutaneous Recombinant Erythropoietin in Prevention of Anemia of Prematurity

机译：口服重组促红细胞生成素和皮下重组促红细胞生成素预防早产贫血的比较

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

摘要
著录项
相似文献
相关主题

摘要

BackgroundPremature neonates are at risk for severe anemia and erythropoietin is the most important hormone in erythropoiesis. The aim of this study was to evaluate the influence of oral recombinant human erythropoietin (rhEPO) in proving erythropoiesis in neonates.

机译：背景早产儿有严重贫血的危险，促红细胞生成素是促红细胞生成中最重要的激素。这项研究的目的是评估口服重组人促红细胞生成素（rhEPO）对新生儿促红细胞生成的影响。

著录项

期刊名称 Iranian Red Crescent Medical Journal
作者
R Saeidi; A Banihashem; M Hammoud; M Gholami;
展开▼
作者单位

展开▼
年(卷),期 2019(14),3
年度 2019
页码 178–181
总页数 4
原文格式 PDF
正文语种
中图分类
关键词
Anemia, Prematurity, Recombinant erythropoietin, Newborn;

机译：贫血;早产;重组促红细胞生成素;新生儿;

相似文献

外文文献
中文文献
专利

1. Comparison of Oral Recombinant Erythropoietin and Subcutaneous Recombinant Erythropoietin in Prevention of Anemia of Prematurity [J] . Iranian red crescent medical journal . 2012,第3期

机译：口服重组促红细胞生成素和皮下重组促红细胞生成素预防早产贫血的比较
2. Comparison between two and five doses a week of recombinant human erythropoietin for anemia of prematurity: a randomized trial. [J] . Brown MS, Keith JF-3rd Pediatrics: Official Publication of the American Academy of Pediatrics . 1999,第2aPta1期

机译：每周两次和五次重组人促红细胞生成素治疗早产儿贫血的比较：一项随机试验。
3. Comparison Between Two and Five Doses a Week of Recombinant Human Erythropoietin for Anemia of Prematurity: A Randomized Trial [J] . Julian F. Keith III, Mark S. Brown Pediatrics: Official Publication of the American Academy of Pediatrics . 1999,第2期

机译：每周两次和五个剂量重组人促红细胞生成素治疗早产儿贫血的比较：一项随机试验
4. Recombinant Human Erythropoietin as a Cause of Non-Regenerative Anemia in a Stable of Racing Thoroughbreds [C] . C. Schwarzwald, K. W. Hinchcliff Annual Convention of the American Association of Equine Practitioners . 2004

机译：重组人促红细胞生成素作为一种稳定的赛车型血统非再生性贫血的原因
5. Pharmacokinetic and Pharmacodynamic Modeling of Recombinant Human Erythropoietin: The Basis for Improvement of Personalized Anemia Management [D] . Nguyen, Ly Minh. 2021

机译：重组人促红细胞生成素的药代动力学和药效模型：改进个性化贫血管理的基础
6. Anemia lessens and its prevention with recombinant human erythropoietin worsens glomerular injury and hypertension in rats with reduced renal mass. [O] . D L Garcia, S Anderson, H G Rennke, 1988

机译：贫血减轻用重组人促红细胞生成素预防贫血可加重肾病大鼠的肾小球损伤和高血压。
7. 97 Cost-Benefit Analysis of Prevention of Neonatal Anemia with Recombinant Human Erythropoietin in Premature Infants [O] . I Glorieux, J Tricoire, N Afchar, 2004

机译：97预防新生儿贫血与重组人促红细胞生成素治疗早产儿的成本效益分析

Comparison of Oral Recombinant Erythropoietin and Subcutaneous Recombinant Erythropoietin in Prevention of Anemia of Prematurity

摘要

著录项

相似文献

相关主题

期刊订阅